Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.

Landgren, Ola; Hofmann, Jonathan N; McShane, Charlene M; Santo, Loredana; Hultcrantz, Malin; Korde, Neha; Mailankody, Sham; Kazandjian, Dickran; Murata, Kazunori; Thoren, Katie; Ramanathan, Lakshmi; Dogan, Ahmet; Rustad, Even; Lu, Sydney X; Akhlaghi, Theresia; Kristinsson, Sigurdur Y; Björkholm, Magnus; Devlin, Sean; Purdue, Mark P; Pfeiffer, Ruth M; Turesson, Ingemar

Landgren, Ola; Hofmann, Jonathan N; McShane, Charlene M; Santo, Loredana; Hultcrantz, Malin; Korde, Neha; Mailankody, Sham; Kazandjian, Dickran; Murata, Kazunori; Thoren, Katie; Ramanathan, Lakshmi; Dogan, Ahmet; Rustad, Even; Lu, Sydney X; Akhlaghi, Theresia; Kristinsson, Sigurdur Y; Björkholm, Magnus; Devlin, Sean; Purdue, Mark P; Pfeiffer, Ruth M; Turesson, Ingemar.

Afiliación

Landgren O; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
McShane CM; Cancer Epidemiology and Health Services Research Group, Centre for Public Health, Queen's University, Belfast, Northern Ireland, United Kingdom.
Santo L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Hultcrantz M; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Korde N; Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Mailankody S; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Kazandjian D; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Murata K; Multiple Myeloma Section, National Cancer Institute, Bethesda, Maryland.
Thoren K; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Ramanathan L; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Dogan A; Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Rustad E; Department of Hematopathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Lu SX; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Akhlaghi T; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Kristinsson SY; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Björkholm M; Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Devlin S; Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
Purdue MP; Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Pfeiffer RM; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Turesson I; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

JAMA Oncol ; 5(9): 1293-1301, 2019 Sep 01.

Article en En | MEDLINE | ID: mdl-31318385

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JAMA Oncol Año: 2019 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google